Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8230478 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 8 Pages |
Abstract
Despite exceeding commonly cited spinal cord dose constraints, SRS for spinal hemangioblastomas is safe and effective. Consistent with animal experiments, these data support a partial-volume tolerance model for the human spinal cord. Because irradiated cord volumes were generally small, application of these data to other clinical scenarios should be made cautiously. Further prospective studies of spinal radiosurgery are needed.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Megan E. M.D., Clara Y.H. M.D., Ph.D., Iris C. M.D., John R. M.D., Steven D. M.D., Robert E. M.D., Scott G. M.D.,